FDA Clears Lilly’s Foundayo Pill
WASHINGTON — Federal health regulators approved Eli Lilly’s oral obesity medicine Foundayo (orforglipron), creating a new daily pill option in the fast-growing GLP-1 market, according to U.S. Food and Drug…
Ethical Objective Balanced Sentinel
Where truth stands guard
WASHINGTON — Federal health regulators approved Eli Lilly’s oral obesity medicine Foundayo (orforglipron), creating a new daily pill option in the fast-growing GLP-1 market, according to U.S. Food and Drug…